Skip to main content

Peer Review reports

From: Characteristics and outcomes of patients with COVID-19 at high risk of disease progression receiving sotrovimab, oral antivirals, or no treatment: a retrospective cohort study

Original Submission
23 Aug 2023 Submitted Original manuscript
18 Oct 2023 Reviewed Reviewer Report
2 Nov 2023 Reviewed Reviewer Report - Eleanor J. Hothersall
25 Jan 2024 Author responded Author comments - Myriam Drysdale
Resubmission - Version 2
25 Jan 2024 Submitted Manuscript version 2
7 Feb 2024 Author responded Author comments - Myriam Drysdale
Resubmission - Version 3
7 Feb 2024 Submitted Manuscript version 3
21 Mar 2024 Author responded Author comments - Myriam Drysdale
Resubmission - Version 4
21 Mar 2024 Submitted Manuscript version 4
14 Apr 2024 Reviewed Reviewer Report - Eleanor J. Hothersall
19 Jun 2024 Author responded Author comments - Myriam Drysdale
Resubmission - Version 5
19 Jun 2024 Submitted Manuscript version 5
Publishing
27 Jun 2024 Editorially accepted
4 Jul 2024 Article published 10.1186/s12879-024-09576-7

You can find further information about peer review here.

Back to article page